nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—Vandetanib—KDR—age related macular degeneration	0.0634	0.541	CrCbGaD
Erlotinib—Vandetanib—VEGFA—age related macular degeneration	0.0538	0.459	CrCbGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00155	0.00175	CbGpPWpGaD
Erlotinib—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00154	0.00175	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—CCL2—age related macular degeneration	0.00153	0.00173	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—SQSTM1—age related macular degeneration	0.00152	0.00172	CbGpPWpGaD
Erlotinib—EGFR—Disease—NMNAT1—age related macular degeneration	0.00149	0.00169	CbGpPWpGaD
Erlotinib—EGFR—Disease—RDH8—age related macular degeneration	0.00149	0.00169	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—CD36—age related macular degeneration	0.00147	0.00167	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—RHO—age related macular degeneration	0.00146	0.00166	CbGpPWpGaD
Erlotinib—ABCG2—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00146	0.00165	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CFH—age related macular degeneration	0.00146	0.00165	CbGpPWpGaD
Erlotinib—ABL2—Axon guidance—VEGFA—age related macular degeneration	0.00145	0.00164	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CFI—age related macular degeneration	0.00143	0.00162	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00142	0.00161	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CFB—age related macular degeneration	0.00141	0.0016	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00141	0.0016	CbGpPWpGaD
Erlotinib—EGFR—Immune System—C9—age related macular degeneration	0.00141	0.0016	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.0014	0.00159	CbGpPWpGaD
Erlotinib—CYP1A1—PPARA activates gene expression—CD36—age related macular degeneration	0.00138	0.00156	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—NMNAT1—age related macular degeneration	0.00137	0.00155	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—ABCA4—age related macular degeneration	0.00137	0.00155	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.00136	0.00154	CbGpPWpGaD
Erlotinib—JAK3—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00136	0.00154	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00135	0.00153	CbGpPWpGaD
Erlotinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—age related macular degeneration	0.00135	0.00153	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—RAD51B—age related macular degeneration	0.00134	0.00152	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CFHR3—age related macular degeneration	0.00133	0.00151	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00132	0.00149	CbGpPWpGaD
Erlotinib—EGFR—Disease—RPE65—age related macular degeneration	0.0013	0.00147	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.0013	0.00147	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—NMNAT1—age related macular degeneration	0.00128	0.00145	CbGpPWpGaD
Erlotinib—MAP2K5—Focal Adhesion—VEGFA—age related macular degeneration	0.00125	0.00142	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.00125	0.00141	CbGpPWpGaD
Erlotinib—EPHA6—Axon guidance—VEGFA—age related macular degeneration	0.00122	0.00139	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CFI—age related macular degeneration	0.00122	0.00139	CbGpPWpGaD
Erlotinib—EGFR—Focal Adhesion—KDR—age related macular degeneration	0.00122	0.00138	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00121	0.00137	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ELOVL4—age related macular degeneration	0.0012	0.00136	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—RHO—age related macular degeneration	0.00119	0.00135	CbGpPWpGaD
Erlotinib—ABL1—Immune System—C2—age related macular degeneration	0.00119	0.00134	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00117	0.00132	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—NMNAT1—age related macular degeneration	0.00116	0.00132	CbGpPWpGaD
Erlotinib—JAK3—Immune System—SQSTM1—age related macular degeneration	0.00115	0.0013	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CFHR3—age related macular degeneration	0.00114	0.00129	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ELOVL4—age related macular degeneration	0.00112	0.00127	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00111	0.00126	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TGFBR1—age related macular degeneration	0.00109	0.00123	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—RHO—age related macular degeneration	0.00108	0.00123	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00108	0.00122	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00108	0.00122	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00106	0.0012	CbGpPWpGaD
Erlotinib—EGFR—Disease—ABCA4—age related macular degeneration	0.00105	0.00119	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RDH8—age related macular degeneration	0.00104	0.00118	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00104	0.00117	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—VEGFA—age related macular degeneration	0.00104	0.00117	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ELOVL4—age related macular degeneration	0.00102	0.00115	CbGpPWpGaD
Erlotinib—EGFR—Immune System—C2—age related macular degeneration	0.00101	0.00115	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.001	0.00113	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CFH—age related macular degeneration	0.000992	0.00112	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000987	0.00112	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000986	0.00112	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—SLC16A8—age related macular degeneration	0.000967	0.0011	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CFB—age related macular degeneration	0.000962	0.00109	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000947	0.00107	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000947	0.00107	CbGpPWpGaD
Erlotinib—ABL1—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.000943	0.00107	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—KDR—age related macular degeneration	0.00093	0.00105	CbGpPWpGaD
Erlotinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.00093	0.00105	CbGpPWpGaD
Erlotinib—EGFR—Disease—RHO—age related macular degeneration	0.000913	0.00103	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RPE65—age related macular degeneration	0.000912	0.00103	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—SLC16A8—age related macular degeneration	0.000902	0.00102	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—C3—age related macular degeneration	0.000881	0.000998	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—VEGFA—age related macular degeneration	0.000873	0.000989	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000865	0.00098	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CFH—age related macular degeneration	0.000848	0.00096	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000841	0.000952	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NMNAT1—age related macular degeneration	0.000834	0.000945	CbGpPWpGaD
Erlotinib—MKNK1—Disease—APOE—age related macular degeneration	0.000833	0.000944	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CFB—age related macular degeneration	0.000822	0.000931	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—SLC16A8—age related macular degeneration	0.000821	0.00093	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000821	0.000929	CbGpPWpGaD
Erlotinib—EGFR—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.000806	0.000913	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—C3—age related macular degeneration	0.0008	0.000906	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—KDR—age related macular degeneration	0.000794	0.0009	CbGpPWpGaD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.000789	0.000894	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NMNAT1—age related macular degeneration	0.000788	0.000893	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000782	0.000886	CbGpPWpGaD
Erlotinib—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.000772	0.000874	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD36—age related macular degeneration	0.000771	0.000874	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—CD36—age related macular degeneration	0.000768	0.00087	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—CD36—age related macular degeneration	0.000753	0.000853	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000744	0.000843	CbGpPWpGaD
Erlotinib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.000735	0.000833	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ABCA4—age related macular degeneration	0.000735	0.000833	CbGpPWpGaD
Erlotinib—JAK3—Immune System—C3—age related macular degeneration	0.000731	0.000828	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	0.000729	0.000826	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.000723	0.000819	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.000719	0.000815	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NMNAT1—age related macular degeneration	0.000719	0.000814	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—VEGFA—age related macular degeneration	0.0007	0.000793	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CRP—age related macular degeneration	0.000695	0.000788	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ELOVL4—age related macular degeneration	0.000689	0.000781	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.000683	0.000774	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CD36—age related macular degeneration	0.000678	0.000768	CbGpPWpGaD
Erlotinib—EGFR—Focal Adhesion—VEGFA—age related macular degeneration	0.000671	0.00076	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFBR1—age related macular degeneration	0.000669	0.000758	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000668	0.000757	CbGpPWpGaD
Erlotinib—JAK3—Immune System—TLR4—age related macular degeneration	0.000667	0.000755	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—KDR—age related macular degeneration	0.000663	0.000752	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—CD36—age related macular degeneration	0.000656	0.000743	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—C3—age related macular degeneration	0.000642	0.000728	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RHO—age related macular degeneration	0.000639	0.000724	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000638	0.000723	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.000632	0.000716	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00063	0.000713	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ELOVL4—age related macular degeneration	0.000628	0.000712	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—C3—age related macular degeneration	0.000627	0.00071	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CCL2—age related macular degeneration	0.000626	0.000709	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000616	0.000698	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CRP—age related macular degeneration	0.000611	0.000692	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—SQSTM1—age related macular degeneration	0.000606	0.000687	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000601	0.000681	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000593	0.000672	CbGpPWpGaD
Erlotinib—ABL1—Immune System—SQSTM1—age related macular degeneration	0.000589	0.000667	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.000588	0.000666	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—TLR4—age related macular degeneration	0.000586	0.000664	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000585	0.000663	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—APOE—age related macular degeneration	0.000583	0.000661	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000582	0.000659	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD36—age related macular degeneration	0.000579	0.000656	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—KDR—age related macular degeneration	0.000572	0.000647	CbGpPWpGaD
Erlotinib—EGFR—Disease—CST3—age related macular degeneration	0.000571	0.000647	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—KDR—age related macular degeneration	0.000567	0.000642	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000565	0.00064	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000562	0.000636	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD36—age related macular degeneration	0.000556	0.00063	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—SLC16A8—age related macular degeneration	0.000555	0.000629	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.00055	0.000623	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—C3—age related macular degeneration	0.000549	0.000622	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000534	0.000605	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00053	0.000601	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—C3—age related macular degeneration	0.000527	0.000597	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CRP—age related macular degeneration	0.000522	0.000592	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000519	0.000588	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFBR1—age related macular degeneration	0.000513	0.000581	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—VEGFA—age related macular degeneration	0.000512	0.00058	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.000509	0.000577	CbGpPWpGaD
Erlotinib—ALB—Metabolism—SLC16A8—age related macular degeneration	0.000506	0.000574	CbGpPWpGaD
Erlotinib—EGFR—Immune System—SQSTM1—age related macular degeneration	0.000503	0.00057	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.000503	0.000569	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—TLR4—age related macular degeneration	0.000501	0.000567	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—LIPC—age related macular degeneration	0.000495	0.000561	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CCL2—age related macular degeneration	0.00049	0.000555	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CETP—age related macular degeneration	0.000478	0.000541	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—C3—age related macular degeneration	0.000473	0.000535	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000468	0.00053	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—LIPC—age related macular degeneration	0.000462	0.000523	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CETP—age related macular degeneration	0.000445	0.000505	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000444	0.000503	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—APOE—age related macular degeneration	0.00044	0.000498	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000439	0.000498	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—VEGFA—age related macular degeneration	0.000438	0.000496	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—KDR—age related macular degeneration	0.000431	0.000488	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—LIPC—age related macular degeneration	0.00042	0.000476	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000418	0.000474	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000407	0.000461	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CETP—age related macular degeneration	0.000405	0.000459	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD36—age related macular degeneration	0.000395	0.000447	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000393	0.000445	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000388	0.000439	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—C3—age related macular degeneration	0.000385	0.000436	CbGpPWpGaD
Erlotinib—ABL1—Immune System—C3—age related macular degeneration	0.000374	0.000424	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—CD36—age related macular degeneration	0.000371	0.00042	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00037	0.000419	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CCL2—age related macular degeneration	0.00037	0.000419	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—VEGFA—age related macular degeneration	0.000366	0.000414	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFBR1—age related macular degeneration	0.000359	0.000407	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—APOE—age related macular degeneration	0.000359	0.000406	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—VEGFA—age related macular degeneration	0.000359	0.000406	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CRP—age related macular degeneration	0.000356	0.000403	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000354	0.000401	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—KDR—age related macular degeneration	0.000351	0.000398	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—C3—age related macular degeneration	0.00035	0.000396	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000342	0.000388	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TLR4—age related macular degeneration	0.000341	0.000387	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000339	0.000384	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000339	0.000384	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000337	0.000382	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD36—age related macular degeneration	0.000337	0.000382	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000337	0.000382	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000327	0.00037	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SQSTM1—age related macular degeneration	0.000325	0.000369	CbGpPWpGaD
Erlotinib—EGFR—Immune System—C3—age related macular degeneration	0.00032	0.000362	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—VEGFA—age related macular degeneration	0.000315	0.000357	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—VEGFA—age related macular degeneration	0.000312	0.000354	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CRP—age related macular degeneration	0.000304	0.000345	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCL2—age related macular degeneration	0.000301	0.000341	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000301	0.000341	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000299	0.000339	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000298	0.000337	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TLR4—age related macular degeneration	0.000292	0.00033	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CETP—age related macular degeneration	0.00029	0.000329	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CD36—age related macular degeneration	0.000287	0.000325	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—LIPC—age related macular degeneration	0.000284	0.000322	CbGpPWpGaD
Erlotinib—EGFR—Disease—APOE—age related macular degeneration	0.000275	0.000311	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CETP—age related macular degeneration	0.000274	0.000311	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCL2—age related macular degeneration	0.000274	0.00031	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000273	0.00031	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CD36—age related macular degeneration	0.000268	0.000303	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.000261	0.000295	CbGpPWpGaD
Erlotinib—ALB—Metabolism—LIPC—age related macular degeneration	0.000259	0.000294	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—APOE—age related macular degeneration	0.000253	0.000287	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000252	0.000285	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CETP—age related macular degeneration	0.00025	0.000283	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CD36—age related macular degeneration	0.000244	0.000276	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—VEGFA—age related macular degeneration	0.000237	0.000269	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—APOE—age related macular degeneration	0.000236	0.000268	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000236	0.000267	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000227	0.000257	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CETP—age related macular degeneration	0.000219	0.000248	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—APOE—age related macular degeneration	0.000215	0.000243	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000214	0.000242	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000208	0.000236	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—C3—age related macular degeneration	0.000207	0.000234	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000206	0.000234	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—VEGFA—age related macular degeneration	0.000194	0.000219	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—APOE—age related macular degeneration	0.000192	0.000218	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—KDR—age related macular degeneration	0.000189	0.000214	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000181	0.000205	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—VEGFA—age related macular degeneration	0.000177	0.0002	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000175	0.000198	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CD36—age related macular degeneration	0.000175	0.000198	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CD36—age related macular degeneration	0.000165	0.000187	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL2—age related macular degeneration	0.000162	0.000183	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—APOE—age related macular degeneration	0.000154	0.000174	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CD36—age related macular degeneration	0.000151	0.000171	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CD36—age related macular degeneration	0.00015	0.00017	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOE—age related macular degeneration	0.000145	0.000165	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.00014	0.000159	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000135	0.000153	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOE—age related macular degeneration	0.000133	0.000151	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOE—age related macular degeneration	0.000133	0.00015	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CD36—age related macular degeneration	0.000132	0.000149	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000124	0.000141	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOE—age related macular degeneration	0.000116	0.000132	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000109	0.000124	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000105	0.000119	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—VEGFA—age related macular degeneration	0.000104	0.000118	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOE—age related macular degeneration	9.27e-05	0.000105	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CD36—age related macular degeneration	8.11e-05	9.19e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOE—age related macular degeneration	7.16e-05	8.11e-05	CbGpPWpGaD
